SRZN

28.4607.21%
YL

Yang Li

Executive Vice President of Research

Dr. Yang Li, Ph.D., serves as Executive Vice President of Research at Surrozen, Inc. since July 2023 and served as its Senior Vice President of Biology since January 2021 until June 2023 and also served as its Vice President of Biology from October 2017 to December 2020. He has experience in both large and small molecule drug discovery research and development. Most recently, Dr. Li was Scientific Director at Amgen, where his teams helped advance multiple programs into the clinic in a variety of disease indications including antivirals, diabetes, obesity, dyslipidemia, kidney and cardiovascular disease. In this role, he also oversaw external alliances with academic collaborators, advised on department research strategies and served as Global Discovery Research Lead on a clinical-stage program. Dr. Li also led innovative approaches to explore secreted factors and their receptors for target discovery and pioneered an agonistic antibody program to endocrine FGF receptors. Dr. Li holds a Ph.D. degree in Cell Biology from Stanford University and was trained in the laboratory of Nobel Laureate, Dr. Roger Kornberg. He also holds dual B.S. degrees in Chemistry and Molecular and Cell Biology from Pennsylvania State University.

Positions